Seher YAYLACI

Dr. Seher YAYLACI

Lokman Hekim Üniversitesi, Ankara, Turkey (Türkiye)
orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 January 2016 in Biomacromolecules
Verified
Journal Article
Closed access
SYSeher YAYLACI
Seher YAYLACI
MEMelis Sardan Ekiz
Melis Sardan Ekiz
EAElif Arslan
Elif Arslan
NCNuray Can
Nuray Can
EKErden Kilic
Erden Kilic
Mustafa O.  GulerMustafa O. Guler
Mustafa O. Guler

7 April 2016 in ACS Biomaterials Science & Engineering
Verified
Journal Article
Closed access
SYSeher YAYLACI
Seher YAYLACI
MSMerve Sen
Merve Sen
OBOzlem Bulut
Ozlem Bulut
EAElif Arslan
Elif Arslan
MGMustafa O. Guler
Mustafa O. Guler
ATAyse Begum Tekinay
Ayse Begum Tekinay

17 May 2023 in Scientific Reports
Verified
Journal Article
Open access
PDF file
SYSeher YAYLACI
Seher YAYLACI
DKDemet Kaçaroğlu
Demet Kaçaroğlu
ÖHÖzgür Hürkal
Özgür Hürkal
AUAlper Murat Ulaşlı
Alper Murat Ulaşlı
Adipose tissue derived stromal cells (ADSCs) play a crucial role in research and applications of regenerative medicine because they can be rapidly isolated in high quantities. Nonetheless, their purity, pluripotency, differentiation capacity, and stem cell marker expression might vary greatly depending on technique and tools used for extraction and harvesting. There are two methods described in the literature for isolating regenerative cells from adipose tissue. The first technique is enzymatic digestion, which utilizes many enzymes to remove stem cells from the tissue they reside in. The second method involves separating the concentrated adipose tissue using non-enzymatic, mechanical separation methods. ADSCs are isolated from the stromal-vascular fraction (SVF) of processed lipoaspirate, which is the lipoaspirate's aqueous portion. The purpose of this work was to evaluate a unique device ‘microlyzer’ for generating SVF from adipose tissue using a mechanical technique that required minimal intervention. The Microlyzer was examined using tissue samples from ten different patients. The cells that were retrieved were characterized in terms of their cell survival, phenotype, proliferation capacity, and differentiation potential. The number of progenitor cells extracted only from the microlyzed tissue was in comparable amount to the number of progenitor cells acquired by the gold standard enzymatic approach. The cells that were collected from each group exhibit similar levels of viability as well as proliferation rates. In addition, the differentiation potentials of the cells derived from the microlyzed tissue were investigated, and it was discovered that cells isolated through microlyzer entered the differentiation pathways more quickly and displayed a greater level of marker gene expression than cells isolated by enzymatic methods. These findings suggest that microlyzer, particularly in regeneration investigations, will allow quick and high rate cell separation at the bedside.

6 December 2012 in Biomacromolecules
Verified
Journal Article
Closed access
SYSeher YAYLACI
Seher YAYLACI
ATAysegul Tombuloglu
Aysegul Tombuloglu
MKMurat Kilinc
Murat Kilinc
Mustafa O.  GulerMustafa O. Guler
Mustafa O. Guler
ATAyse Begum Tekinay
Ayse Begum Tekinay

18 April 2023 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
SYSeher YAYLACI
Seher YAYLACI
EDErdem Dinç
Erdem Dinç
BABahri Aydın
Bahri Aydın
ATAyse B. Tekinay
Ayse B. Tekinay
Mustafa O.  GulerMustafa O. Guler
Mustafa O. Guler
Ranibizumab is a recombinant VEGF-A antibody used to treat the wet form of age-related macular degeneration. It is intravitreally administered to ocular compartments, and the treatment requires frequent injections, which may cause complications and patient discomfort. To reduce the number of injections, alternative treatment strategies based on relatively non-invasive ranibizumab delivery are desired for more effective and sustained release in the eye vitreous than the current clinical practice. Here, we present self-assembled hydrogels composed of peptide amphiphile molecules for the sustained release of ranibizumab, enabling local high-dose treatment. Peptide amphiphile molecules self-assemble into biodegradable supramolecular filaments in the presence of electrolytes without the need for a curing agent and enable ease of use due to their injectable nature—a feature provided by shear thinning properties. In this study, the release profile of ranibizumab was evaluated by using different peptide-based hydrogels at varying concentrations for improved treatment of the wet form of age-related macular degeneration. We observed that the slow release of ranibizumab from the hydrogel system follows extended- and sustainable release patterns without any dose dumping. Moreover, the released drug was biologically functional and effective in blocking the angiogenesis of human endothelial cells in a dose-dependent manner. In addition, an in vivo study shows that the drug released from the hydrogel nanofiber system can stay in the rabbit eye’s posterior chamber for longer than a control group that received only a drug injection. The tunable physiochemical characteristics, injectable nature, and biodegradable and biocompatible features of the peptide-based hydrogel nanofiber show that this delivery system has promising potential for intravitreal anti-VEGF drug delivery in clinics to treat the wet form age-related macular degeneration.

7 November 2022 in Regenerative Biomaterials
Verified
Journal Article
Open access
PDF file
SYSeher YAYLACI
Seher YAYLACI
MGMustafa O Guler
Mustafa O Guler
ATAyse B Tekinay
Ayse B Tekinay
Articular cartilage, which is exposed to continuous repetitive compressive stress, has limited self-healing capacity in the case of trauma. Thus, it is crucial to develop new treatment options for the effective regeneration of the cartilage tissue. Current cellular therapy treatment options are microfracture and autologous chondrocyte implantation; however, these treatments induce the formation of fibrous cartilage, which degenerates over time, rather than functional hyaline cartilage tissue. Tissue engineering studies using biodegradable scaffolds and autologous cells are vital for developing an effective long-term treatment option. 3D scaffolds composed of glycosaminoglycan-like peptide nanofibers are synthetic, bioactive, biocompatible, and biodegradable and trigger cell–cell interactions that enhance chondrogenic differentiation of cells without using any growth factors. We showed differentiation of mesenchymal stem cells into chondrocytes in both 2D and 3D culture, which produce a functional cartilage extracellular matrix, employing bioactive cues integrated into the peptide nanofiber scaffold without adding exogenous growth factors.